coronavirus vaccine
More News
-
China develops new vaccine ‘most effective against Covid variants’
Research shows 79% efficacy against Delta variant and overall 67% efficacy against any variant
-
Infection rate reaches 8.48% in Pindi
Anti-Covid jabs being administered by Punjab health dept
-
First batch of homemade vaccine to be available by month-end: Umar
The CanSino vaccine will go through a rigorous quality control checks at NIH, says NCOC chief
-
Rahul Gandhi warns 'explosive' Covid wave threatens India and the world
Says India had a responsibility in 'a globalised and interconnected world'
-
Pakistan has received 4.06 million doses of Covid vaccines so far
Out of the total vaccines, Sindh has received 0.92 million doses
-
Pakistanis aged 50-59 to get Covid-19 shots from next week
Asad Umar once again encourages everyone to register themselves for the vaccination drive
-
Thailand reports fourth record daily rise in coronavirus cases this week
The country has received two million doses of China’s Sinovac shots and 117,300 AstraZeneca shots
-
In pictures: Young Pakistanis rush to purchase Russian vaccine as private sales open
Thousands of Pakistanis rushed to get inoculated in the first round of commercial sales of Covid-19 vaccines
-
EU seeks 10 million AstraZeneca vaccines from India to meet shortfall
Any quick approval is unlikely as India is scrambling to expand its own domestic vaccination drive, says official
-
Immune response may be linked to AstraZeneca vaccine clot issue
Four previously healthy individuals who got the AstraZeneca shot and developed life-threatening clots
-
Pfizer, BioNTech launch Covid-19 vaccine trial in kids under 12
First volunteers in early-stage trial were given their first injections on Wednesday, says Pfizer spokesperson
-
Technology behind Pfizer's Covid-19 vaccine can be used to fight cancer
Both Pfizer/BioNTech and Moderna use messenger RNA (mRNA) to send genetic instructions to the human body's cells
-
DRAP okays emergency use of Sinopharm shots for people above 60
Earlier, the Chinese vaccine was being administered to people up to the age of 60 years
-
Simultaneous start of vaccination drive provides equal opportunity to all provinces: Faraz
Information minister praises Prime Minister Imran Khan's Covid-19 strategy
-
Fresh data show toll South African virus variant takes on vaccine efficacy
Mutants have a diminishing effect on the efficacy of the vaccines, confirms Dr Anthony Fauci
-
Coronavirus variants escape effects of antibody drugs
Antibody vaccines for treating Covid-19 are less effective against some of the new variants of coronavirus
-
South African virus variant may resist antibody drugs
Covid-19 vaccine from Pfizer and BioNTech SE is likely to protect against the more infectious variant of the virus
-
WHO, marking year since Covid-19 began, urges fair vaccine distribution to all
This is the challenge we must rise to in the New Year, says Tedros Adhanom Ghebreyesus, WHO director-general
-
Explainer-The new coronavirus variant in Britain: How worrying is it?
Strain is said to be up to 70% more transmissible than the previously dominant strain in UK
-
Private sector allowed to procure Covid vaccine, insists Dr Nausheen
DRAP will monitor entire process from import to sale of vaccine to ensure transparency, says parliamentary secretary
-
US hits 16 million Covid cases even as vaccine begins roll-out
Millions of doses vaccine were expected to start rolling out across the United States on Sunday
-
Govt to start Covid-19 vaccination drive in April
Parliamentary secretary says vaccines will be provided free of charge
-
Two coronavirus vaccines available in US in coming weeks: health secretary
Federal government will ship the vaccines through its normal vaccine distribution system, says Alex Azar
-
'Ten Covid-19 vaccines could be available by mid-2021'
Vaccines by Pfizer, BioNtech have shown promising results, says head of the global pharmaceutical industry group
-
AstraZeneca CEO says co likely to run new global trial on Covid-19 vaccine
AstraZeneca is facing tricky questions about its success rate that could hinder chances of getting speedy approval
-
US, Europe plan vaccination schemes as second virus wave builds
Global hopes of beating the pandemic are high after US biotech firm Moderna announces nearly 95% effectiveness
-
Factbox: Moderna Covid-19 vaccine stability eases distribution challenges
Vaccine is stable for up to six months at a temperature of minus 20 degrees Celsius, about home freezer levels
-
Hong Kong scientists say anti-microbe drug successful against coronavirus
Anti-microbial drug used to treat stomach ulcers and infections have shown promise in combatting coronavirus
-
Scientists see downsides to top Covid-19 vaccines from Russia, China
High-profile Covid-19 vaccines developed in Russia and China share a potential shortcoming
-
Chinese pharmaceutical company's Covid-19 vaccine will be ready by end of the year
Covid-19 vaccine will cost less than $140
-
CanSino to start Phase III trial of Covid-19 vaccine in Saudi
No Covid-19 vaccine has been approved for commercial use
-
Multiple vaccine candidates show early promise; inhaled interferon helps severe Covid-19 patients
Results from trials of two potential Covid-19 vaccines yielded initial signs of efficacy
-
Oxford vaccine 'safe, helps immune reactions'
Though today’s results were widely welcomed, larger trials still need to take place to determine vaccine’s efficacy
-
Russian scientists hail results of Covid-19 vaccine trial
More than 100 possible vaccines are being developed and tested around the world to try to stop the pandemic
-
'At war time speed', China leads Covid-19 vaccine race
China has brought state, military and private sectors together in a quest to combat coronavirus
-
'At war time speed', China leads Covid-19 vaccine race
China has brought state, military and private sectors together in a quest to combat coronavirus
-
Inflammation key to severe Covid-19 in high-risk groups; plasma therapy only right for some patients
Study of high-risk Covid-19 patients may explain why their health issues contribute to more severe cases of illness
-
WHO halts hydroxychloroquine, HIV drugs in covid trials after failure to reduce death
A WHO-led trial is looking at the potential effect of Gilead’s antiviral drug remdesivir on Covid-19
-
Scientists hunt pandemic hotspots in race to test vaccines
A vaccine is seen as essential to ending a pandemic that has killed nearly 370,000 people
-
India backs hydroxychloroquine for Covid-19 prevention despite WHO suspension
Indian Council of Medical Research says it should be continued because there is no harm
-
Coronavirus vaccine shows rapid immune response in its first human trial
The vaccine did not cause any serious adverse effects
-
Scientists in China believe new drug can stop pandemic 'without vaccine'
Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt
-
Germany expects Covid-19 vaccine by year's end
Paul-Ehrlich-Institut says he is hopeful ongoing vaccine research projects will achieve progress soon
-
Russia aiming for coronavirus vaccine tests in June
First batch of possible vaccines may be available by late July, says health minister
-
WHO sees 'potentially positive data' on Covid-19 treatments
'very tricky viruses' that are 'difficult to produce vaccines against', says WHO official
-
'Promising' virus-fighting antibody found: study
antibody offers the potential to prevent and/or treat Covid-19, says author of the research study
-
Neutralising antibody is the new virus detail to aid vaccine research
Researchers have produced a monoclonal antibody that can "neutralise" the new coronavirus
-
Karachi University team identifies potential drugs for Covid-19 treatment
Remdesivir was earlier found effective against the infection during an international drug trial
-
Japan aims to fast-track review of anti-viral drug remdesivir
Japan has confirmed nearly 15,000 cases and 517 deaths from Covid-19
-
Covid-19: Effectiveness of the antiviral drug remdesivir still in question
A US study published this week raised great hope for the effectiveness of the antiviral drug remdesivir